Dr. Martens saw a 13% stock rally after a positive first half and maintained guidance for fiscal 2025. Despite a 25% drop in 2024, the brand is optimistic about new products and direct-to-consumer sales growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
